BRIELLYN
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BRIELLYN, covering 2011-03-22 to 2022-04-29. Get the full timeline:
Most recent: FDA Approved: BRIELLYN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)